NIH-funded preclinical studies suggest designer drug may treat ALS and spinocerebellar ataxia 2 In two studies of mice, researchers showed that a drug, engineered to combat the gen... Read more
The first in a new class of gene-silencing drugs, known as inclisiran, has halved cholesterol levels in patients at risk of cardiovascular disease. The findings come from the large... Read more